SCHEMBL1474944

SCHEMBL1474944

COc1ccc(N2CCN(CCNC(=O)c3cc(-c4ccco4)on3)CC2)c(OC)c1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
DRD2 P14416 3/20 0.56
DRD3 P35462 2/20 0.56
DRD4 P21917 2/20 0.55
LMNA P02545 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
MAPT P10636 1/20 0.55
HTT P42858 1/20 0.55
KDM4E B2RXH2 1/20 0.54
HSD17B10 Q99714 1/20 0.54
NPC1 O15118 2/20 0.52
TP53 P04637 1/20 0.52
GAA P10253 1/20 0.52
HPGD P15428 1/20 0.52
RAB9A P51151 1/20 0.52
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
HTR1A P08908 1/20 0.51
ADRA1A P35348 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1474730 0.91 ALDH1A1 (0.68) ALDH1A1DRD2DRD3DRD4LMNA
SCHEMBL1475255 0.88 ALDH1A1 (0.62) ALDH1A1DRD2DRD3DRD4LMNA
SCHEMBL15190456 0.88 DRD2 (0.49) ALDH1A1DRD2DRD3DRD4
SCHEMBL1474195 0.87 DRD4 (0.58) ALDH1A1DRD2DRD3DRD4LMNA
SCHEMBL1474506 0.87 ALDH1A1 (0.58) ALDH1A1DRD2DRD3DRD4LMNA
SCHEMBL1477057 0.84 ALDH1A1 (0.64) ALDH1A1DRD2DRD3LMNASMN1; SMN2
SCHEMBL1474491 0.83 KDM4E (0.56) ALDH1A1DRD2DRD3LMNASMN1; SMN2
SCHEMBL1477101 0.81 RAB9A (0.67) ALDH1A1LMNASMN1; SMN2MAPTHTT
SCHEMBL1474960 0.80 ALDH1A1 (0.64) ALDH1A1LMNASMN1; SMN2MAPTHTT
SCHEMBL1476629 0.79 ALDH1A1 (0.62) ALDH1A1DRD2DRD4LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7915297-B2 Isoxazole derivatives and use thereof SK HOLDINGS CO., LTD. (KR) 2011-03-29 US disclosed
US-7915297-B2 Isoxazole derivatives and use thereof SK HOLDINGS CO., LTD. (KR) 2011-03-29 US disclosed
US-7915297-B2 Isoxazole derivatives and use thereof SK HOLDINGS CO., LTD. (KR) 2011-03-29 US disclosed
US-20090131336-A1 Isoxazole Derivatives and Use Thereof SK BIOPHARMACEUTICALS CO., LTD. (KR) 2009-05-21 US disclosed
US-20090131336-A1 Isoxazole Derivatives and Use Thereof SK BIOPHARMACEUTICALS CO., LTD. (KR) 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131336-A1 Isoxazole Derivatives and Use Thereof WNT3A, WNT1, WNT3 ALDH1A1 706/4885DRD2 3882/4885DRD3 3114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.